Gabather AB (publ) Cash Flow Conversion Efficiency

Latest as of March 2026: -0.117x

Gabather AB (publ) cash flow conversion efficiency. Based on the latest financial reports, Gabather AB (publ) (GABA) has a cash flow conversion efficiency ratio of -0.117x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-331.00K ≈ $-35.62K USD) by net assets (Skr2.82 Million ≈ $303.48K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Gabather AB (publ) (2014–2025)

Cash flow conversion efficiency of Gabather AB (publ) from 2014 to 2025. This chart illustrates how Gabather AB (publ)'s cash flow conversion efficiency has evolved over time, based on yearly financial data. View latest Gabather AB (publ) stock price today for real-time trading data and today's change.

Gabather AB (publ) Cash Flow Conversion Ratio Explained

Gabather AB (publ) cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Gabather AB (publ) Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Gabather AB (publ) ranked by their cash flow conversion efficiency. Also see Gabather AB (publ) (GABA) market capitalisation for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Artelo Biosciences Inc NASDAQ:ARTL	-1.007x
Nextgen TA:NXGN	0.111x
MUZHU MINING LTD F:Y33	N/A
Vault Strategic Mining Corp. V:KNOX	-1.008x
Grupo Vasconia S.A.B MX:VASCONI	0.006x
Quartix Holdings Plc LSE:QTX	0.121x
OZZ Resources Ltd AU:OZZ	0.105x
GENERAL COPPER GOLD CORP. F:7S50	0.169x

Annual Cash Flow Conversion Efficiency for Gabather AB (publ) (2014–2025)

The table below shows the annual cash flow conversion efficiency of Gabather AB (publ) from 2014 to 2025. Review GABA cash flow after capex ratio to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	Skr-863.00K ≈ $-92.87K	Skr-7.22 Million ≈ $-777.42K	8.371x	+950.12%
2024-12-31	Skr-4.17 Million ≈ $-449.30K	Skr-3.33 Million ≈ $-358.15K	0.797x	+103.33%
2023-12-31	Skr486.00K ≈ $52.30K	Skr-11.64 Million ≈ $-1.25 Million	-23.957x	-758.22%
2022-12-31	Skr3.44 Million ≈ $369.98K	Skr-9.60 Million ≈ $-1.03 Million	-2.791x	-89.90%
2021-12-31	Skr10.96 Million ≈ $1.18 Million	Skr-16.12 Million ≈ $-1.73 Million	-1.470x	-209.74%
2020-12-31	Skr28.85 Million ≈ $3.10 Million	Skr-13.69 Million ≈ $-1.47 Million	-0.475x	-51.21%
2019-12-31	Skr43.59 Million ≈ $4.69 Million	Skr-13.68 Million ≈ $-1.47 Million	-0.314x	+75.16%
2018-12-31	Skr15.87 Million ≈ $1.71 Million	Skr-20.05 Million ≈ $-2.16 Million	-1.264x	-497.58%
2017-12-31	Skr45.76 Million ≈ $4.92 Million	Skr-9.68 Million ≈ $-1.04 Million	-0.211x	+0.97%
2016-12-31	Skr33.19 Million ≈ $3.57 Million	Skr-7.09 Million ≈ $-762.54K	-0.214x	+50.12%
2015-12-31	Skr12.79 Million ≈ $1.38 Million	Skr-5.47 Million ≈ $-588.95K	-0.428x	-141796.96%
2014-12-31	Skr8.63 Million ≈ $929.25K	Skr-2.60K ≈ $-280.32	0.000x	--

About Gabather AB (publ)

ST:GABA Sweden Drug Manufacturers - Specialty & Generic

Market Cap

$1.31 Million

Skr12.21 Million SEK

Market Cap Rank

#30457 Global

#695 in Sweden

Share Price

Skr0.02

Change (1 day)

+0.00%

52-Week Range

Skr0.02 - Skr0.06

All Time High

Skr71.87